PMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ProMIS Neurosciences Inc (PMN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show some neutral to slightly positive signals, there are no significant catalysts, recent news, or strong trading trends to support a compelling investment case. Additionally, the lack of financial data and valuation metrics makes it difficult to assess the company's growth potential. For now, it is best to hold off on investing in PMN until more concrete data or positive catalysts emerge.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 60.745, and moving averages are converging, suggesting indecision in the market. Key support and resistance levels are Pivot: 10.018, R1: 10.698, S1: 9.339, R2: 11.117, S2: 8.919.
Analyst Brookline initiated a Buy rating with a $40 price target, which is significantly higher than the current price.
No recent news, no significant trading trends from hedge funds or insiders, and no recent congress trading data. Post-market price change is negative (-3.65%).
No financial data available for analysis.
Brookline initiated coverage with a Buy rating and a $40 price target on 2026-05-20, indicating long-term optimism.
